Abstract
Latency-associated transcript (LAT) significantly enhances the spontaneous reactivation phenotype of herpes simplex virus type 1 (HSV-1). The mechanism by which LAT accomplishes this has been elusive. To determine if LAT’s antiapoptosis activity is involved, the authors used a rabbit eye model to analyze the spontaneous reactivation phenotype of an HSV-1 mutant in which LAT was replaced by an unrelated antiapoptosis gene. This virus, dLAT-cpIAP, contains the open reading frame of the baculovirus inhibitor of apoptosis protein gene (cpIAP) in place of LAT, under control of the LAT promoter. The authors report here that in a rabbit ocular model of infection, dLAT-cpIAP had a spontaneous reactivation phenotype similar to wild-type virus and significantly higher than LAT(−) viruses. This was consistent with their previous findings using the mouse trigeminal ganglia explant—induced reactivation model. Whether LAT (and in the case of dLAT-cpIAP, cpIAP) enhances the spontaneous reactivation phenotype by functioning during establishment of latency, maintenance of latency, or reactivation from latency, or during two or more of these periods, remains to be determined. Regardless, the results presented in this study strongly support the hypothesis that LAT’s antiapoptosis activity is the dominant function that enhances HSV-1’s spontaneous reactivation phenotype.
References
Ahmed M, Lock M, Miller CG, Fraser NW (2002). Regions of the herpes simplex virus type 1 latency-associated transcript that protect cells from apoptosis in vitro and protect neuronal cells in vivo. J Virol 76: 717–729.
Birnbaum MJ, Clem RJ, Miller LK (1994). An apoptosis-inhibiting gene from a nuclear polyhedrosis virus encoding a polypeptide with Cys/His sequence motifs. J Virol 68: 2521–2528.
Block TM, Deshmane S, Masonis J, Maggioncalda J, Valyi-Nagi T, Fraser NW (1993). An HSV LAT null mutant reactivates slowly from latent infection and makes small plaques on CV-1 monolayers. Virology 192: 618–630.
Ciacci-Zanella J, Stone M, Henderson G, Jones C (1999). The latency-related gene of bovine herpesvirus 1 inhibits programmed cell death. J Virol 73: 9734–9740.
Clem RJ, Miller LK (1994). Control of programmed cell death by the baculovirus genes p35 and iap. Mol Cell Biol 14: 5212–5222.
Crook NE, Clem RJ, Miller LK (1993). An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif. J Virol 67: 2168–2174.
Cui C, Griffiths A, Li G, Silva LM, Kramer MF, Gaasterland T, Wang XJ, Coen DM (2006). Prediction and identification of herpes simplex virus 1-encoded microRNAs. J Virol 80: 5499–5508.
Deatly AM, Spivack JG, Lavi E, Fraser NW (1987). RNA from an immediate early region of the type 1 herpes simplex virus genome is present in the trigeminal ganglia of latently infected mice. Proc Natl Acad Sci U S A 84: 3204–3208.
Devi-Rao GB, Bloom DC, Stevens JG, Wagner EK (1994). Herpes simplex virus type 1 DNA replication and gene expression during explant-induced reactivation of latently infected murine sensory ganglia. J Virol 68: 1271–1282.
Drolet BS, Perng GC, Cohen J, Slanina SM, Yukht A, Nesburn AB, Wechsler SL (1998). The region of the herpes simplex virus type 1 LAT gene involved in spontaneous reactivation does not encode a functional protein. Virology 242: 221–232.
Drolet B, Perng G, Villosis R, Slanina S, Nesburn A, Wechsler S (1999). Expression of the first 811 nucleotides of the HSV-1 latency associated transcript (LAT) paritally restores wild type spontaneous reactivation to a LAT null mutant. Virology 253: 96–106.
Fleming DT, McQuillan GM, Johnson RE, Nahmias AJ, Aral SO, Lee FK, St Louis ME (1997). Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 337: 1105–1111.
Gebhardt BM, Halford WP (2005). Evidence that spontaneous reactivation of herpes virus does not occur in mice. Virol J 2: 67.
Goins WF, Sternberg LR, Croen KD, Krause PR, Hendricks RL, Fink DJ, Straus SE, Levine M, Glorioso JC (1994). A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats. J Virol 68: 2239–2252.
Gupta A, Gartner JJ, Sethupathy P, Hatzigeorgiou AG, Fraser NW (2006). Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript. Nature 442: 82–85.
Hill JM, Maggioncalda JB, Garza HH Jr, Su YH, Fraser NW, Block TM (1996). In vivo epinephrine reactivation of ocular herpes simplex virus type 1 in the rabbit is correlated to a 370-base-pair region located between the promoter and the 5′ end of the 2.0 kilobase latency-associated transcript. J Virol 70: 7270–7274.
Hill JM, Sedarati F, Javier RT, Wagner EK, Stevens JG (1990). Herpes simplex virus latent phase transcription facilitates in vivo reactivation. Virology 174: 117–125.
Huang Q, Deveraux QL, Maeda S, Salvesen GS, Stennicke HR, Hammock BD, Reed JC (2000). Evolutionary conservation of apoptosis mechanisms: lepidopteran and baculoviral inhibitor of apoptosis proteins are inhibitors of mammalian caspase-9. Proc Natl Acad Sci U S A 97: 1427–1432.
Inman M, Lovato L, Doster A, Jones C (2001a). A mutation in the latency-related gene of bovine herpesvirus 1 leads to impaired ocular shedding in acutely infected calves. J Virol 75: 8507–8515.
Inman M, Perng G, Henderson G, Ghiasi H, Nesburn A, Wechsler S, Jones C (2001b). Region of Herpes Simplex Virus type 1 latency-associated transcript sufficient for wild type spontaneous reactivation promotes cell survival in tissue culture. J Virol 75: 3636–3646.
Jin L, Peng W, Perng GC, Brick DJ, Nesburn AB, Jones C, Wechsler SL (2003). Identification of herpes simplex virus type 1 latency-associated transcript sequences that both inhibit apoptosis and enhance the spontaneous reactivation phenotype. J Virol 77: 6556–6561.
Jin L, Perng GC, Mott KR, Osorio N, Naito J, Brick DJ, Carpenter D, Jones C, Wechsler SL (2005). A herpes simplex virus type 1 mutant expressing a baculovirus inhibitor of apoptosis gene in place of latency-associated transcript has a wild-type reactivation phenotype in the mouse. J Virol 79: 12286–12295.
Jones C, Newby TJ, Holt T, Doster A, Stone M, Ciacci-Zanella J, Webster CJ, Jackwood MW (2000). Analysis of latency in cattle after inoculation with a temperature sensitive mutant of bovine herpesvirus 1 (RLB106). Vaccine 18: 3185–3195.
Leib DA, Bogard CL, Kosz-Vnenchak M, Hicks KA, Coen DM, Knipe DM, Schaffer PA (1989). A deletion mutant of the latency-associated transcript of herpes simplex virus type 1 reactivates from the latent state with reduced frequency. J Virol 63: 2893–2900.
Liesegang TJ (1989). Epidemiology of ocular herpes simplex. Natural history in Rochester, Minn, 1950 through 1982. Arch Ophthalmol 107: 1160–1165.
Liesegang TJ, Melton LJ 3rd, Daly PJ, Ilstrup DM (1989). Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982. Arch Ophthalmol 107: 1155–1159.
Loutsch JM, Perng GC, Hill JM, Zheng X, Marquart ME, Block TM, Ghiasi H, Nesburn AB, Wechsler SL (1999). Identical 371-base-pair deletion mutations in the LAT genes of herpes simplex virus type 1 McKrae and 17syn+ result in different in vivo reactivation phenotypes. J Virol 73: 767–771.
Maggioncalda J, Mehta A, Bagasra O, Fraser NW, Block TM (1996). A herpes simplex virus type 1 mutant with a deletion immediately upstream of the LAT locus establishes latency and reactivates from latently infected mice with normal kinetics. J NeuroVirol 2: 268–278.
Mott KR, Osorio N, Jin L, Brick DJ, Naito J, Cooper J, Henderson G, Inman M, Jones C, Wechsler SL, Perng GC (2003). The bovine herpesvirus-1 LR ORF2 is critical for this gene’s ability to restore the high wild-type reactivation phenotype to a herpes simplex virus-1 LAT null mutant. J Gen Virol 84: 2975–2985.
Perng G, Jones C, Ciacci-Zanella H, Henderson G, Yukht A, Slanina S, Hofman F, Ghiasi H, Nesburn A, Wechsler S (2000a). Virus induced neuronal apoptosis blocked by the herpes simplex virus latency associated transcript (LAT). Science 287: 1500–1503.
Perng GC, Dunkel EC, Geary PA, Slanina SM, Ghiasi H, Kaiwar R, Nesburn AB, Wechsler SL (1994). The latency-associated transcript gene of herpes simplex virus type 1 (HSV-1) is required for efficient in vivo spontaneous reactivation of HSV-1 from latency. J Virol 68: 8045–8055.
Perng GC, Esmaili D, Slanina SM, Yukht A, Ghiasi H, Osorio N, Mott KR, Maguen B, Jin L, Nesburn AB, Wechsler SL (2001a). Three herpes simplex virus type 1 latency-associated transcript mutants with distinct and asymmetric effects on virulence in mice compared with rabbits. J Virol 75: 9018–9028.
Perng GC, Ghiasi H, Slanina SM, Nesburn AB, Wechsler SL (1996a). The spontaneous reactivation function of the herpes simplex virus type 1 LAT gene resides completely within the first 1.5 kilobases of the 8.3-kilobase primary transcript. J Virol 70: 976–984.
Perng GC, Maguen B, Jin L, Mott KR, Osorio N, Slanina SM, Yukht A, Ghiasi H, Nesburn AB, Inman M, Henderson G, Jones C, Wechsler SL (2002). A gene capable of blocking apoptosis can substitute for the herpes simplex virus type 1 latency-associated transcript gene and restore wild-type reactivation levels. J Virol 76: 1224–1235.
Perng GC, Slanina SM, Ghiasi H, Nesburn AB, Wechsler SL (1996b). A 371-nucleotide region between the herpes simplex virus type 1 (HSV-1) LAT promoter and the 2-kilobase LAT is not essential for efficient spontaneous reactivation of latent HSV-1. J Virol 70: 2014–2018.
Perng GC, Slanina SM, Ghiasi H, Nesburn AB, Wechsler SL (2001b). The effect of latency-associated transcript on the herpes simplex virus type 1 latency-reactivation phenotype is mouse strain-dependent. J Gen Virol 82: 1117–1122.
Perng GC, Slanina SM, Yuhkt A, Ghiasi H, Nesburn AB, Wechsler SL (1999). Herpes simplex virus type 1 serum neutralizing antibody titers increase during latency in rabbits latently infected with LAT positive but not LAT negative viruses. J Virol 73: 9669–9672.
Perng GC, Slanina SM, Yukht A, Ghiasi H, Nesburn AB, Wechsler SL (2000b). The latency-associated transcript gene enhances establishment of herpes simplex virus type 1 latency in rabbits. J Virol 74: 1885–1891.
Rock DL, Nesburn AB, Ghiasi H, Ong J, Lewis TL, Lokensgard JR, Wechsler SL (1987). Detection of latency-related viral RNAs in trigeminal ganglia of rabbits latently infected with herpes simplex virus type 1. J Virol 61: 3820–3826.
Sawtell NM, Thompson RL (1992). Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency. J Virol 66: 2157–2169.
Steiner I, Spivack JG, Lirette RP, Brown SM, MacLean AR, Subak-Sharpe JH, Fraser NW (1989). Herpes simplex virus type 1 latency-associated transcripts are evidently not essential for latent infection. EMBO J 8: 505–511.
Stevens JG, Wagner EK, Devi-Rao GB, Cook ML, Feldman LT (1987). RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science 235: 1056–1059.
Vilaplana L, O’Reilly DR (2003). Functional interaction between Cydia pomonella granulovirus IAP proteins. Virus Res 92: 107–111.
Wald A, Zeh J, Selke S, Warren T, Ryncarz AJ, Ashley R, Krieger JN, Corey L (2000). Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 342: 844–850.
Whitley RJ (1996). Herpes simplex virus. In: Field’s virology. Fields B, Knipe D, Howley P, Chanock R, Melnick J, Monath T (eds). Philadelphia: Lippincott-Raven, pp. 1843–1887.
Whitley RJ, Roizman B (2001). Herpes simplex virus infections. Lancet 357: 1513–1518.
Xu F, Sternberg MR, Kottiri BJ, McQuillan GM, Lee FK, Nahmias AJ, Berman SM, Markowitz LE (2006). Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 296: 964–973.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported by Public Health Service grants EY13191, EY12823, and P20RR15635; USDA grants 2005-01554 and 2006-01627; The Discovery Eye Foundation; The Henry L. Guenther Foundation; and Research to Prevent Blindness.
Rights and permissions
About this article
Cite this article
Jin, L., Perng, GC., Carpenter, D. et al. Reactivation phenotype in rabbits of a herpes simplex virus type 1 mutant containing an unrelated antiapoptosis gene in place of latency-associated transcript. Journal of NeuroVirology 13, 78–84 (2007). https://doi.org/10.1080/13550280601164333
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1080/13550280601164333